craniosynostosis: be treated

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents condition
Weight: 0.56
, symptom
Weight: 0.46
, jaw
Weight: 0.40
Siblings pulmonary edema
Weight: 0.34
, neurofibromatosis
Weight: 0.34
, pelvic inflammatory disease
Weight: 0.34
, cystic fibrosis
Weight: 0.34
, spondylolisthesis
Weight: 0.33

Related properties

Property Similarity
be treated 1.00
is is treated 0.98
be due to salpingitis treated 0.88
be treated in medicine 0.85
be due to acute salpingitis treated 0.82
be treated in alternative medicine 0.79

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.06
Rule weight: 0.13
Evidence weight: 0.49
Similarity weight: 1.00
Evidence: 0.75
¬ Remarkable(craniosynostosis, be treated) ⋁
Evidence: 0.68
¬ Remarkable(neurofibromatosis, be treated)
0.06
Rule weight: 0.13
Evidence weight: 0.54
Similarity weight: 0.88
Evidence: 0.75
¬ Remarkable(craniosynostosis, be treated) ⋁
Evidence: 0.62
¬ Remarkable(pelvic inflammatory disease, be due to salpingitis treated)
0.06
Rule weight: 0.13
Evidence weight: 0.47
Similarity weight: 1.00
Evidence: 0.75
¬ Remarkable(craniosynostosis, be treated) ⋁
Evidence: 0.71
¬ Remarkable(pulmonary edema, be treated)
0.06
Rule weight: 0.13
Evidence weight: 0.56
Similarity weight: 0.82
Evidence: 0.75
¬ Remarkable(craniosynostosis, be treated) ⋁
Evidence: 0.59
¬ Remarkable(pelvic inflammatory disease, be due to acute salpingitis treated)
0.06
Rule weight: 0.13
Evidence weight: 0.46
Similarity weight: 1.00
Evidence: 0.75
¬ Remarkable(craniosynostosis, be treated) ⋁
Evidence: 0.73
¬ Remarkable(cystic fibrosis, be treated)
0.06
Rule weight: 0.13
Evidence weight: 0.46
Similarity weight: 1.00
Evidence: 0.75
¬ Remarkable(craniosynostosis, be treated) ⋁
Evidence: 0.73
¬ Remarkable(cystic fibrosis, be treated)
0.06
Rule weight: 0.13
Evidence weight: 0.55
Similarity weight: 0.79
Evidence: 0.75
¬ Remarkable(craniosynostosis, be treated) ⋁
Evidence: 0.60
¬ Remarkable(pelvic inflammatory disease, be treated in alternative medicine)
0.05
Rule weight: 0.13
Evidence weight: 0.38
Similarity weight: 0.98
Evidence: 0.75
¬ Remarkable(craniosynostosis, be treated) ⋁
Evidence: 0.83
¬ Remarkable(pulmonary edema, is is treated)
0.05
Rule weight: 0.13
Evidence weight: 0.40
Similarity weight: 0.85
Evidence: 0.75
¬ Remarkable(craniosynostosis, be treated) ⋁
Evidence: 0.80
¬ Remarkable(pelvic inflammatory disease, be treated in medicine)

Remarkability from sibling implausibility

0.56
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 0.98
Evidence: 0.41
Plausible(craniosynostosis, be treated) ⋁
Evidence: 0.83
Remarkable(pulmonary edema, is is treated) ⋁
Evidence: 0.51
¬ Plausible(pulmonary edema, is is treated)
0.55
Rule weight: 0.60
Evidence weight: 0.91
Similarity weight: 1.00
Evidence: 0.41
Plausible(craniosynostosis, be treated) ⋁
Evidence: 0.71
Remarkable(pulmonary edema, be treated) ⋁
Evidence: 0.53
¬ Plausible(pulmonary edema, be treated)
0.54
Rule weight: 0.60
Evidence weight: 0.90
Similarity weight: 1.00
Evidence: 0.41
Plausible(craniosynostosis, be treated) ⋁
Evidence: 0.68
Remarkable(neurofibromatosis, be treated) ⋁
Evidence: 0.54
¬ Plausible(neurofibromatosis, be treated)
0.53
Rule weight: 0.60
Evidence weight: 0.88
Similarity weight: 1.00
Evidence: 0.41
Plausible(craniosynostosis, be treated) ⋁
Evidence: 0.73
Remarkable(cystic fibrosis, be treated) ⋁
Evidence: 0.73
¬ Plausible(cystic fibrosis, be treated)
0.53
Rule weight: 0.60
Evidence weight: 0.88
Similarity weight: 1.00
Evidence: 0.41
Plausible(craniosynostosis, be treated) ⋁
Evidence: 0.73
Remarkable(cystic fibrosis, be treated) ⋁
Evidence: 0.73
¬ Plausible(cystic fibrosis, be treated)
0.48
Rule weight: 0.60
Evidence weight: 0.93
Similarity weight: 0.85
Evidence: 0.41
Plausible(craniosynostosis, be treated) ⋁
Evidence: 0.80
Remarkable(pelvic inflammatory disease, be treated in medicine) ⋁
Evidence: 0.55
¬ Plausible(pelvic inflammatory disease, be treated in medicine)
0.42
Rule weight: 0.60
Evidence weight: 0.79
Similarity weight: 0.88
Evidence: 0.41
Plausible(craniosynostosis, be treated) ⋁
Evidence: 0.62
Remarkable(pelvic inflammatory disease, be due to salpingitis treated) ⋁
Evidence: 0.94
¬ Plausible(pelvic inflammatory disease, be due to salpingitis treated)
0.39
Rule weight: 0.60
Evidence weight: 0.81
Similarity weight: 0.79
Evidence: 0.41
Plausible(craniosynostosis, be treated) ⋁
Evidence: 0.60
Remarkable(pelvic inflammatory disease, be treated in alternative medicine) ⋁
Evidence: 0.81
¬ Plausible(pelvic inflammatory disease, be treated in alternative medicine)
0.38
Rule weight: 0.60
Evidence weight: 0.77
Similarity weight: 0.82
Evidence: 0.41
Plausible(craniosynostosis, be treated) ⋁
Evidence: 0.59
Remarkable(pelvic inflammatory disease, be due to acute salpingitis treated) ⋁
Evidence: 0.95
¬ Plausible(pelvic inflammatory disease, be due to acute salpingitis treated)

Salient implies Plausible

0.19
Rule weight: 0.28
Evidence weight: 0.69
Similarity weight: 1.00
Evidence: 0.41
Plausible(craniosynostosis, be treated) ⋁
Evidence: 0.54
¬ Salient(craniosynostosis, be treated)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.88
Similarity weight: 1.00
Evidence: 0.54
Salient(craniosynostosis, be treated) ⋁
Evidence: 0.35
¬ Typical(craniosynostosis, be treated) ⋁
Evidence: 0.75
¬ Remarkable(craniosynostosis, be treated)

Typical implies Plausible

0.38
Rule weight: 0.48
Evidence weight: 0.79
Similarity weight: 1.00
Evidence: 0.41
Plausible(craniosynostosis, be treated) ⋁
Evidence: 0.35
¬ Typical(craniosynostosis, be treated)

Typicality and Rermarkability incompatibility between siblings

0.09
Rule weight: 0.14
Evidence weight: 0.69
Similarity weight: 0.98
Evidence: 0.75
¬ Remarkable(craniosynostosis, be treated) ⋁
Evidence: 0.41
¬ Typical(pulmonary edema, is is treated)
0.08
Rule weight: 0.14
Evidence weight: 0.61
Similarity weight: 1.00
Evidence: 0.75
¬ Remarkable(craniosynostosis, be treated) ⋁
Evidence: 0.51
¬ Typical(pulmonary edema, be treated)
0.08
Rule weight: 0.14
Evidence weight: 0.59
Similarity weight: 1.00
Evidence: 0.75
¬ Remarkable(craniosynostosis, be treated) ⋁
Evidence: 0.55
¬ Typical(neurofibromatosis, be treated)
0.07
Rule weight: 0.14
Evidence weight: 0.63
Similarity weight: 0.85
Evidence: 0.75
¬ Remarkable(craniosynostosis, be treated) ⋁
Evidence: 0.50
¬ Typical(pelvic inflammatory disease, be treated in medicine)
0.06
Rule weight: 0.14
Evidence weight: 0.45
Similarity weight: 1.00
Evidence: 0.75
¬ Remarkable(craniosynostosis, be treated) ⋁
Evidence: 0.74
¬ Typical(cystic fibrosis, be treated)
0.06
Rule weight: 0.14
Evidence weight: 0.45
Similarity weight: 1.00
Evidence: 0.75
¬ Remarkable(craniosynostosis, be treated) ⋁
Evidence: 0.74
¬ Typical(cystic fibrosis, be treated)
0.04
Rule weight: 0.14
Evidence weight: 0.35
Similarity weight: 0.79
Evidence: 0.75
¬ Remarkable(craniosynostosis, be treated) ⋁
Evidence: 0.86
¬ Typical(pelvic inflammatory disease, be treated in alternative medicine)
0.03
Rule weight: 0.14
Evidence weight: 0.27
Similarity weight: 0.88
Evidence: 0.75
¬ Remarkable(craniosynostosis, be treated) ⋁
Evidence: 0.98
¬ Typical(pelvic inflammatory disease, be due to salpingitis treated)
0.03
Rule weight: 0.14
Evidence weight: 0.26
Similarity weight: 0.82
Evidence: 0.75
¬ Remarkable(craniosynostosis, be treated) ⋁
Evidence: 0.99
¬ Typical(pelvic inflammatory disease, be due to acute salpingitis treated)